Highlights
- Market Cap
- $47.90M
- Enterprise Value
- $22.12M
- EPS (TTM)
- -$3.11
- Total Revenue (TTM)
- $182.67M
- Gross Profit (TTM)
- $52.94M
- EBITDA (TTM)
- -$48.68M
- Year Range
- $1.57 - $4.32
- Target Price
- $11.00
- ROA (TTM)
- -73.74%
- ROE (TTM)
- -197.98%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in PetMed Express, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
PetMed Express, Inc. (PETS) has returned -28.75% so far this year and -45.58% over the past 12 months. Over the last ten years, PETS has returned -15.97% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.
PetMed Express, Inc.
- 1D
- 3.17%
- 1M
- -16.79%
- YTD
- -28.75%
- 6M
- -9.16%
- 1Y
- -45.58%
- 3Y*
- -47.28%
- 5Y*
- -40.04%
- 10Y*
- -15.97%
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Apr 26, 1999, PETS's average daily return is +0.10%, while the average monthly return is +1.44%. At this rate, your investment would double in approximately 4.0 years.
Historically, 48% of months were positive and 52% were negative. The best month was Mar 2001 with a return of +202.4%, while the worst month was Jul 2004 at -48.9%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 11 months.
On a daily basis, PETS closed higher 46% of trading days. The best single day was Apr 20, 2000 with a return of +88.2%, while the worst single day was May 5, 2000 at -37.5%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.31% | -14.11% | -16.79% | -28.75% | |||||||||
| 2025 | -1.24% | -7.14% | -5.20% | -19.33% | 9.47% | -10.27% | -6.02% | -1.60% | -18.24% | 2.39% | -31.91% | 82.86% | -33.61% |
| 2024 | -17.86% | -18.52% | -5.34% | -17.54% | 7.85% | -4.93% | -6.42% | -15.83% | 15.36% | 11.41% | 12.93% | 4.10% | -36.24% |
| 2023 | 21.36% | -11.25% | -13.53% | -5.36% | -3.51% | -5.23% | 6.24% | -21.24% | -9.05% | -32.78% | 0.58% | 9.09% | -54.76% |
| 2022 | 2.26% | 5.64% | -4.27% | -15.12% | 2.11% | -9.67% | 9.65% | -4.43% | -5.10% | 9.22% | -5.65% | -10.61% | -25.83% |
| 2021 | 20.03% | -9.14% | 1.34% | -16.35% | -0.73% | 10.21% | -1.44% | -11.36% | -2.43% | 5.81% | -2.84% | -7.68% | -18.17% |
Benchmark Metrics
PetMed Express, Inc. has an annualized alpha of 22.05%, beta of 0.58, and R² of 0.02 versus S&P 500 Index. Calculated based on daily prices since April 27, 1999.
- This stock participated in 86.60% of S&P 500 Index downside but only 48.48% of its upside — more exposed to losses than it benefited from rallies.
- Beta of 0.58 may look defensive, but with R² of 0.02 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R² of 0.02 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 22.05%
- Beta
- 0.58
- R²
- 0.02
- Upside Capture
- 48.48%
- Downside Capture
- 86.60%
Return for Risk
Risk / Return Rank
PETS ranks 17 for risk / return — in the bottom 17% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for PetMed Express, Inc. (PETS) and compare them to a chosen benchmark (S&P 500 Index).
| PETS | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.46 | 0.90 | -1.36 |
Sortino ratioReturn per unit of downside risk | -0.37 | 1.39 | -1.75 |
Omega ratioGain probability vs. loss probability | 0.95 | 1.21 | -0.26 |
Calmar ratioReturn relative to maximum drawdown | -0.74 | 1.40 | -2.14 |
Martin ratioReturn relative to average drawdown | -1.47 | 6.61 | -8.07 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore PETS risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
PetMed Express, Inc. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $0.90 | $1.20 | $1.18 | $1.11 | $1.08 | $1.04 | $0.79 | $0.75 | $0.71 |
Dividend yield | 0.00% | 0.00% | 0.00% | 11.90% | 6.78% | 4.67% | 3.46% | 4.59% | 4.47% | 1.74% | 3.25% | 4.14% |
Monthly Dividends
The table displays the monthly dividend distributions for PetMed Express, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.30 | $0.00 | $0.00 | $0.00 | $0.30 | $0.00 | $0.30 | $0.00 | $0.00 | $0.00 | $0.00 | $0.90 |
| 2022 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $1.20 |
| 2021 | $0.28 | $0.00 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $0.00 | $0.30 | $0.00 | $1.18 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the PetMed Express, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the PetMed Express, Inc. was 98.29%, occurring on Feb 2, 2001. Recovery took 688 trading sessions.
The current PetMed Express, Inc. drawdown is 94.88%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.29% | Apr 30, 1999 | 446 | Feb 2, 2001 | 688 | Oct 31, 2003 | 1134 |
| -96.4% | Jan 28, 2021 | 1222 | Dec 8, 2025 | — | — | — |
| -70.23% | Jan 22, 2018 | 370 | Jul 11, 2019 | 390 | Jan 27, 2021 | 760 |
| -68.36% | Feb 13, 2004 | 116 | Jul 30, 2004 | 320 | Nov 3, 2005 | 436 |
| -63.24% | Apr 23, 2010 | 366 | Oct 3, 2011 | 947 | Jul 10, 2015 | 1313 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of PetMed Express, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how PetMed Express, Inc. is priced in the market compared to other companies in the Pharmaceutical Retailers industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for PETS relative to other companies in the Pharmaceutical Retailers industry. Currently, PETS has a P/S ratio of 0.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for PETS in comparison with other companies in the Pharmaceutical Retailers industry. Currently, PETS has a P/B value of 1.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |